Suppr超能文献

胃癌:对危险因素、诊断方法、可能的治疗方案以及初级保健作用的见解。

Gastric carcinoma: Insights into risk factors, methods of diagnosis, possible lines of management, and the role of primary care.

作者信息

Marghalani Aliyah M, Bin Salman Thekra O, Faqeeh Fawaz J, Asiri Mohammed K, Kabel Ahmed M

机构信息

Pharm D, College of Pharmacy, Taif University, Taif, KSA.

Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, KSA, Egypt.

出版信息

J Family Med Prim Care. 2020 Jun 30;9(6):2659-2663. doi: 10.4103/jfmpc.jfmpc_527_20. eCollection 2020 Jun.

Abstract

Gastric carcinoma represents the second most common type of malignancy that contributes to cancer-related mortality worldwide. However, the geographic incidence of gastric carcinoma had changed over the last few decades, possibly due to increased hygiene, increased awareness of the importance of healthy nutrition, and increased rates of eradication of infection. Gastric carcinoma consists of two pathological variants, intestinal and diffuse. Early cases of gastric carcinoma may be asymptomatic. However, advanced cases may present with significant weight loss, dysphagia, abdominal pain, vomiting, and even severe upper gastrointestinal bleeding. Patients at high risk of developing gastric carcinoma should be adequately screened at primary healthcare centers for early detection and effective management. Lines of treatment vary according to the stage of the disease but surgical resection of the tumor with regional lymphadenectomy remains the gold standard of therapy. This review sheds light on gastric carcinoma given the recent trends regarding its prevalence, risk factors, types, clinical picture, methods of diagnosis, possible lines of management, and the role of primary care.

摘要

胃癌是导致全球癌症相关死亡的第二大常见恶性肿瘤类型。然而,在过去几十年中,胃癌的地理发病率发生了变化,这可能归因于卫生条件的改善、对健康营养重要性认识的提高以及感染根除率的上升。胃癌有两种病理变体,即肠型和弥漫型。早期胃癌可能没有症状。然而,晚期病例可能出现显著体重减轻、吞咽困难、腹痛、呕吐,甚至严重的上消化道出血。胃癌高危患者应在初级医疗保健中心进行充分筛查,以便早期发现和有效管理。治疗方案根据疾病阶段而异,但肿瘤手术切除加区域淋巴结清扫仍然是治疗的金标准。鉴于近期胃癌在患病率、危险因素、类型、临床表现、诊断方法、可能的治疗方案以及初级保健作用方面的趋势,本综述对胃癌进行了阐述。

相似文献

1
Gastric carcinoma: Insights into risk factors, methods of diagnosis, possible lines of management, and the role of primary care.
J Family Med Prim Care. 2020 Jun 30;9(6):2659-2663. doi: 10.4103/jfmpc.jfmpc_527_20. eCollection 2020 Jun.
2
Gastric cancer: epidemiology, prevention, classification, and treatment.
Cancer Manag Res. 2018 Feb 7;10:239-248. doi: 10.2147/CMAR.S149619. eCollection 2018.
3
Prevalence of Helicobacter pylori infection in advanced gastric carcinoma.
Arq Gastroenterol. 2006 Oct-Dec;43(4):288-92. doi: 10.1590/s0004-28032006000400009.
7
Current approaches to gastric cancer in Peru and Mexico.
Transl Gastroenterol Hepatol. 2017 May 26;2:55. doi: 10.21037/tgh.2017.05.06. eCollection 2017.
9
Review article: Helicobacter pylori and gastric cancer--the clinicians'point of view.
Aliment Pharmacol Ther. 2000 Oct;14 Suppl 3:48-54. doi: 10.1046/j.1365-2036.2000.00100.x.
10
Role of Helicobacter pylori in gastric carcinoma.
Natl Med J India. 1995 Mar-Apr;8(2):58-60.

引用本文的文献

3
From guidelines to radiology practice: navigating the 2023 ASCO guidelines for advanced gastroesophageal cancer and beyond.
Abdom Radiol (NY). 2025 Jan;50(1):78-93. doi: 10.1007/s00261-024-04499-y. Epub 2024 Aug 9.
4
Pembrolizumab in combination with trastuzumab for treatment of HER2-positive advanced gastric or gastro-esophageal junction cancer.
Ann Med Surg (Lond). 2024 Jun 21;86(8):4647-4656. doi: 10.1097/MS9.0000000000002305. eCollection 2024 Aug.
6
Identification and classification of the genomes of novel microviruses in poultry slaughterhouse.
Front Microbiol. 2024 May 2;15:1393153. doi: 10.3389/fmicb.2024.1393153. eCollection 2024.
7
Matrix Metalloproteinase-2 (MMP-2): As an Essential Factor in Cancer Progression.
Recent Pat Anticancer Drug Discov. 2025;20(1):26-44. doi: 10.2174/0115748928251754230922095544.
9
Knowledge and Awareness About Gastric Cancer Among the General Population in Al-Baha City, Saudi Arabia.
Cureus. 2023 May 28;15(5):e39589. doi: 10.7759/cureus.39589. eCollection 2023 May.
10
MFAP2 enhances cisplatin resistance in gastric cancer cells by regulating autophagy.
PeerJ. 2023 Jun 7;11:e15441. doi: 10.7717/peerj.15441. eCollection 2023.

本文引用的文献

1
Esophageal, gastric cancer and immunotherapy: small steps in the right direction?
Transl Gastroenterol Hepatol. 2020 Jan 5;5:9. doi: 10.21037/tgh.2019.09.05. eCollection 2020.
2
Gastric Cancer in Young Adults: A Different Clinical Entity from Carcinogenesis to Prognosis.
Gastroenterol Res Pract. 2020 Mar 2;2020:9512707. doi: 10.1155/2020/9512707. eCollection 2020.
3
A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer.
Onco Targets Ther. 2020 Feb 28;13:1797-1807. doi: 10.2147/OTT.S239336. eCollection 2020.
4
Efficacy and safety of elemene combined with chemotherapy in advanced gastric cancer: A Meta-analysis.
Medicine (Baltimore). 2020 Mar;99(11):e19481. doi: 10.1097/MD.0000000000019481.
5
Combination versus single-agent as palliative chemotherapy for gastric cancer.
BMC Cancer. 2020 Mar 2;20(1):167. doi: 10.1186/s12885-020-6666-1.
6
Common and Co-Occurring Symptoms Experienced by Patients With Gastric Cancer.
Oncol Nurs Forum. 2020 Mar 1;47(2):187-202. doi: 10.1188/20.ONF.187-202.
7
[Research progresses in targeted therapies for gastric cancer].
Zhonghua Nei Ke Za Zhi. 2020 Feb 1;59(2):148-152. doi: 10.3760/cma.j.issn.0578-1426.2020.02.011.
8
Challenges in the treatment of gastric cancer in the older patient.
Cancer Treat Rev. 2020 Apr;85:101980. doi: 10.1016/j.ctrv.2020.101980. Epub 2020 Feb 10.
9
Risk factors for stomach cancer: a systematic review and meta-analysis.
Epidemiol Health. 2020;42:e2020004. doi: 10.4178/epih.e2020004. Epub 2020 Feb 2.
10
Progress in the treatment of gastric cancer in Japan over the last 50 years.
Ann Gastroenterol Surg. 2020 Jan 30;4(1):21-29. doi: 10.1002/ags3.12306. eCollection 2020 Jan.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验